The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro

Jennifer Y Kasper,1 Maria Iris Hermanns,1 Christian Cavelius,2 Annette Kraegeloh,2 Thomas Jung,3 Rolf Danzebrink,3 Ronald E Unger,1 Charles James Kirkpatrick1 1Institute of Pathology, University Medical Center, Mainz, 2Leibniz Institute for New Materials, 3NanoGate AG, Goettelborn, Saarbrüc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kasper JY, Hermanns MI, Cavelius C, Kraegeloh A, Jung T, Danzebrink R, Unger RE, Kirkpatrick CJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/fcd6f5c6a98541f79ba0efe7c6b8469e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fcd6f5c6a98541f79ba0efe7c6b8469e
record_format dspace
spelling oai:doaj.org-article:fcd6f5c6a98541f79ba0efe7c6b8469e2021-12-02T02:04:23ZThe role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro1178-2013https://doaj.org/article/fcd6f5c6a98541f79ba0efe7c6b8469e2016-12-01T00:00:00Zhttps://www.dovepress.com/the-role-of-the-intestinal-microvasculature-in-inflammatory-bowel-dise-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Jennifer Y Kasper,1 Maria Iris Hermanns,1 Christian Cavelius,2 Annette Kraegeloh,2 Thomas Jung,3 Rolf Danzebrink,3 Ronald E Unger,1 Charles James Kirkpatrick1 1Institute of Pathology, University Medical Center, Mainz, 2Leibniz Institute for New Materials, 3NanoGate AG, Goettelborn, Saarbrücken, Germany Abstract: The microvascular endothelium of the gut barrier plays a crucial role during inflammation in inflammatory bowel disease. We have modified a commonly used intestinal cell model based on the Caco-2 cells by adding microvascular endothelial cells (ISO-HAS-1). Transwell filters were used with intestinal barrier-forming Caco-2 cells on top and the ISO-HAS-1 on the bottom of the filter. The goal was to determine whether this coculture mimics the in vivo situation more closely, and whether the model is suitable to evaluate interactions of, for example, prospective nanosized drug vehicles or contrast agents with this coculture in a physiological and inflamed state as it would occur in inflammatory bowel disease. We monitored the inflammatory responsiveness of the cells (release of IL-8, soluble intercellular adhesion molecule 1, and soluble E-selectin) after exposure to inflammatory stimuli (lipopolysaccharide, TNF-α, INF-γ, IL1-β) and a nanoparticle (Ba/Gd: coprecipitated BaSO4 and Gd(OH)3), generally used as contrast agents. The barrier integrity of the coculture was evaluated via the determination of transepithelial electrical resistance and the apparent permeability coefficient (Papp) of NaFITC. The behavior of the coculture Caco-1/ISO-HAS-1 was compared to the respective monocultures Caco-2 and ISO-HAS-1. Based on transepithelial electrical resistance, the epithelial barrier integrity of the coculture remained stable during incubation with all stimuli, whereas the Papp decreased after exposure to the cytokine mixture (TNF-α, INF-γ, IL1-β, and Ba/Gd). Both the endothelial and epithelial monocultures showed a high inflammatory response in both the upper and lower transwell-compartments. However, in the coculture, inflammatory mediators were only detected on the epithelial side and not on the endothelial side. Thus in the coculture, based on the Papp, the epithelial barrier appears to prevent a potential inflammatory overreaction in the underlying endothelial cells. In summary, this coculture model exhibits in vivo-like features, which cannot be observed in conventional monocultures, making the former more suitable to study interactions with external stimuli. Keywords: intestinal microvasculature, inflammatory bowel disease, intestinal barrier in vitro, Caco-2, ISO-HAS-1, soluble E-selectin, sICAM-1, nanosized gadolinium contrast agentKasper JYHermanns MICavelius CKraegeloh AJung TDanzebrink RUnger REKirkpatrick CJDove Medical Pressarticleintestinal microvasculatureinflammatory bowel diseaseintestinal barrier in vitroCaco-2ISO-HAS-1inflammationnano-sized contrast agentsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 6353-6364 (2016)
institution DOAJ
collection DOAJ
language EN
topic intestinal microvasculature
inflammatory bowel disease
intestinal barrier in vitro
Caco-2
ISO-HAS-1
inflammation
nano-sized contrast agents
Medicine (General)
R5-920
spellingShingle intestinal microvasculature
inflammatory bowel disease
intestinal barrier in vitro
Caco-2
ISO-HAS-1
inflammation
nano-sized contrast agents
Medicine (General)
R5-920
Kasper JY
Hermanns MI
Cavelius C
Kraegeloh A
Jung T
Danzebrink R
Unger RE
Kirkpatrick CJ
The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro
description Jennifer Y Kasper,1 Maria Iris Hermanns,1 Christian Cavelius,2 Annette Kraegeloh,2 Thomas Jung,3 Rolf Danzebrink,3 Ronald E Unger,1 Charles James Kirkpatrick1 1Institute of Pathology, University Medical Center, Mainz, 2Leibniz Institute for New Materials, 3NanoGate AG, Goettelborn, Saarbrücken, Germany Abstract: The microvascular endothelium of the gut barrier plays a crucial role during inflammation in inflammatory bowel disease. We have modified a commonly used intestinal cell model based on the Caco-2 cells by adding microvascular endothelial cells (ISO-HAS-1). Transwell filters were used with intestinal barrier-forming Caco-2 cells on top and the ISO-HAS-1 on the bottom of the filter. The goal was to determine whether this coculture mimics the in vivo situation more closely, and whether the model is suitable to evaluate interactions of, for example, prospective nanosized drug vehicles or contrast agents with this coculture in a physiological and inflamed state as it would occur in inflammatory bowel disease. We monitored the inflammatory responsiveness of the cells (release of IL-8, soluble intercellular adhesion molecule 1, and soluble E-selectin) after exposure to inflammatory stimuli (lipopolysaccharide, TNF-α, INF-γ, IL1-β) and a nanoparticle (Ba/Gd: coprecipitated BaSO4 and Gd(OH)3), generally used as contrast agents. The barrier integrity of the coculture was evaluated via the determination of transepithelial electrical resistance and the apparent permeability coefficient (Papp) of NaFITC. The behavior of the coculture Caco-1/ISO-HAS-1 was compared to the respective monocultures Caco-2 and ISO-HAS-1. Based on transepithelial electrical resistance, the epithelial barrier integrity of the coculture remained stable during incubation with all stimuli, whereas the Papp decreased after exposure to the cytokine mixture (TNF-α, INF-γ, IL1-β, and Ba/Gd). Both the endothelial and epithelial monocultures showed a high inflammatory response in both the upper and lower transwell-compartments. However, in the coculture, inflammatory mediators were only detected on the epithelial side and not on the endothelial side. Thus in the coculture, based on the Papp, the epithelial barrier appears to prevent a potential inflammatory overreaction in the underlying endothelial cells. In summary, this coculture model exhibits in vivo-like features, which cannot be observed in conventional monocultures, making the former more suitable to study interactions with external stimuli. Keywords: intestinal microvasculature, inflammatory bowel disease, intestinal barrier in vitro, Caco-2, ISO-HAS-1, soluble E-selectin, sICAM-1, nanosized gadolinium contrast agent
format article
author Kasper JY
Hermanns MI
Cavelius C
Kraegeloh A
Jung T
Danzebrink R
Unger RE
Kirkpatrick CJ
author_facet Kasper JY
Hermanns MI
Cavelius C
Kraegeloh A
Jung T
Danzebrink R
Unger RE
Kirkpatrick CJ
author_sort Kasper JY
title The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro
title_short The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro
title_full The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro
title_fullStr The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro
title_full_unstemmed The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro
title_sort role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified caco-2 model including endothelial cells resembling the intestinal barrier in vitro
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/fcd6f5c6a98541f79ba0efe7c6b8469e
work_keys_str_mv AT kasperjy theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT hermannsmi theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT caveliusc theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT kraegeloha theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT jungt theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT danzebrinkr theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT ungerre theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT kirkpatrickcj theroleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT kasperjy roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT hermannsmi roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT caveliusc roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT kraegeloha roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT jungt roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT danzebrinkr roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT ungerre roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
AT kirkpatrickcj roleoftheintestinalmicrovasculatureininflammatoryboweldiseasestudieswithamodifiedcaco2modelincludingendothelialcellsresemblingtheintestinalbarrierinvitro
_version_ 1718402750989991936